Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00332787 · ClinicalTrials.gov registry record · NA

Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents

A NA study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT00332787: Completed NA study, sponsored by University of Texas Southwestern Medical Center.

NCT00332787 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00332787, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

This study will determine the optimal length of continuation treatment with fluoxetine for children and adolescents with major depressive disorder, as well as the factors that may contribute to positive response during acute and continuation treatment.

Interventions

  • DRUG Fluoxetine

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2000-06
Est. Completion 2005-10
Phase NA

What the finished NCT00332787 record still lists

NCT00332787 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Fluoxetine is the first listed.

NCT00332787 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00332787 about?

NCT00332787 is a clinical study titled "Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents". This study will determine the optimal length of continuation treatment with fluoxetine for children and adolescents with major depressive disorder, as well as the factors that may contribute to positive response during acute and continuation treatment.

What is the current status of trial NCT00332787?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2000-06. Estimated completion is 2005-10.

What interventions are being tested in trial NCT00332787?

The interventions under investigation include: Fluoxetine (DRUG).

Who is sponsoring clinical trial NCT00332787?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00332787's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00332787, the US trial registry maintained by the National Library of Medicine. NCT00332787 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.